Billiontoone (NASDAQ:BLLN) Trading Up 6.2% – Here’s What Happened

Shares of Billiontoone, Inc. (NASDAQ:BLLN) were up 6.2% during trading on Tuesday . The company traded as high as $111.50 and last traded at $110.3260. Approximately 235,175 shares were traded during trading, a decline of 57% from the average session volume of 545,141 shares. The stock had previously closed at $103.86.

Analyst Ratings Changes

Several research firms have recently weighed in on BLLN. BTIG Research dropped their target price on shares of Billiontoone from $142.00 to $130.00 and set a “buy” rating on the stock in a research report on Thursday, August 6th. Guggenheim started coverage on shares of Billiontoone in a research report on Monday, June 29th. They set a “buy” rating and a $125.00 price objective on the stock. Weiss Ratings reaffirmed a “sell (d+)” rating on shares of Billiontoone in a research report on Friday. Wall Street Zen lowered Billiontoone from a “buy” rating to a “hold” rating in a research report on Saturday, August 8th. Finally, Zacks Research lowered Billiontoone from a “hold” rating to a “strong sell” rating in a research report on Monday, August 31st. Seven research analysts have rated the stock with a Buy rating, two have assigned a Hold rating and two have assigned a Sell rating to the stock. Based on data from MarketBeat, Billiontoone has a consensus rating of “Hold” and an average price target of $125.88.

Billiontoone Trading Up 9.7%

The firm has a market capitalization of $5.38 billion and a PE ratio of 162.55. The company has a debt-to-equity ratio of 0.17, a current ratio of 11.69 and a quick ratio of 11.31. The company has a fifty day moving average of $109.42 and a 200-day moving average of $97.24.

Billiontoone (NASDAQ:BLLN) last issued its earnings results on Wednesday, August 5th. The company reported $0.15 EPS for the quarter, meeting analysts’ consensus estimates of $0.15. Billiontoone had a return on equity of 9.96% and a net margin of 8.04%.The firm had revenue of $109.45 million for the quarter. On average, sell-side analysts anticipate that Billiontoone, Inc. will post 0.83 earnings per share for the current fiscal year.

Insider Transactions at Billiontoone

In other Billiontoone news, SVP Bosch John Roderick Ten sold 1,416 shares of Billiontoone stock in a transaction that occurred on Wednesday, September 9th. The shares were sold at an average price of $97.54, for a total value of $138,116.64. Following the completion of the sale, the senior vice president directly owned 25,051 shares in the company, valued at $2,443,474.54. The trade was a 5.35% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CTO David Tsao sold 20,000 shares of the business’s stock in a transaction that occurred on Wednesday, September 9th. The stock was sold at an average price of $98.77, for a total transaction of $1,975,400.00. Following the completion of the sale, the chief technology officer directly owned 1,000 shares of the company’s stock, valued at $98,770. This represents a 95.24% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last 90 days, insiders sold 248,160 shares of company stock worth $28,404,042. 50.22% of the stock is owned by corporate insiders.

Institutional Investors Weigh In On Billiontoone

A number of large investors have recently bought and sold shares of the business. Integrated Wealth Concepts LLC acquired a new stake in shares of Billiontoone in the second quarter worth about $29,000. MCF Advisors LLC raised its stake in shares of Billiontoone by 330.8% in the 2nd quarter. MCF Advisors LLC now owns 448 shares of the company’s stock valued at $54,000 after acquiring an additional 344 shares in the last quarter. Thrive Wealth Management LLC bought a new position in shares of Billiontoone in the 2nd quarter valued at approximately $240,000. Caitong International Asset Management Co. Ltd acquired a new stake in shares of Billiontoone in the fourth quarter worth $230,000. Finally, Jasper Ridge Partners L.P. acquired a new stake in shares of Billiontoone in the second quarter worth $615,000.

About Billiontoone

BillionToOne, Inc is a molecular diagnostics company that develops blood-based tests designed to provide genetic and health information from small amounts of biological material. The company’s technology uses its proprietary quantitative counting template approach to improve the accuracy and sensitivity of molecular testing.

The company’s primary offerings include UNITY, a portfolio of prenatal genetic tests. These services support screening for chromosomal conditions, single-gene disorders and carrier status, and are designed to help healthcare providers assess fetal and maternal genetic risks using a maternal blood sample.